Click here to get full coverage on BridgeBio Has More Room To Run (NASDAQ:BBIO) - Seeking Alpha

BridgeBio Has More Room To Run (NASDAQ:BBIO)  Seeking Alpha

BridgeBio Has More Room To Run (NASDAQ:BBIO) - Seeking Alpha

Click here to get full coverage on This Biotech Is On A Triple-Digit Run, And Shows No Signs Of Slowing - Investor's Business Daily

This Biotech Is On A Triple-Digit Run, And Shows No Signs Of Slowing  Investor's Business Daily

This Biotech Is On A Triple-Digit Run, And Shows No Signs Of Slowing - Investor's Business Daily

Click here to get full coverage on BridgeBio Pharma (NASDAQ:BBIO) Reaches New 12-Month High - Here's Why - MarketBeat

BridgeBio Pharma (NASDAQ:BBIO) Reaches New 12-Month High - Here's Why  MarketBeat

BridgeBio Pharma (NASDAQ:BBIO) Reaches New 12-Month High - Here's Why - MarketBeat

Click here to get full coverage on First Week of August 2026 Options Trading For BridgeBio Pharma (BBIO) - Nasdaq

First Week of August 2026 Options Trading For BridgeBio Pharma (BBIO)  Nasdaq

First Week of August 2026 Options Trading For BridgeBio Pharma (BBIO) - Nasdaq

Click here to get full coverage on BridgeBio Pharma (BBIO) Valuation After Attruby-Driven Earnings Beat and Renewed Analyst Support - Yahoo Finance

BridgeBio Pharma (BBIO) Valuation After Attruby-Driven Earnings Beat and Renewed Analyst Support  Yahoo Finance

BridgeBio Pharma (BBIO) Valuation After Attruby-Driven Earnings Beat and Renewed Analyst Support - Yahoo Finance

Click here to get full coverage on BridgeBio (Nasdaq: BBIO) to present at Piper Sandler and EvercoreISI conferences - Stock Titan

BridgeBio (Nasdaq: BBIO) to present at Piper Sandler and EvercoreISI conferences  Stock Titan

BridgeBio (Nasdaq: BBIO) to present at Piper Sandler and EvercoreISI conferences - Stock Titan

Click here to get full coverage on Biotech Stock Could Turn 4-Year Peak Into Records - Schaeffer's Investment Research

Biotech Stock Could Turn 4-Year Peak Into Records  Schaeffer's Investment Research

Biotech Stock Could Turn 4-Year Peak Into Records - Schaeffer's Investment Research

Click here to get full coverage on BridgeBio Pharma (BBIO): Assessing Valuation After Strong Attruby Quarter and Upbeat Analyst Outlook - Sahm

BridgeBio Pharma (BBIO): Assessing Valuation After Strong Attruby Quarter and Upbeat Analyst Outlook  Sahm

BridgeBio Pharma (BBIO): Assessing Valuation After Strong Attruby Quarter and Upbeat Analyst Outlook - Sahm

Click here to get full coverage on Assenagon Asset Management S.A. Trims Stake in BridgeBio Pharma, Inc. $BBIO - MarketBeat

Assenagon Asset Management S.A. Trims Stake in BridgeBio Pharma, Inc. $BBIO  MarketBeat

Assenagon Asset Management S.A. Trims Stake in BridgeBio Pharma, Inc. $BBIO - MarketBeat

Click here to get full coverage on BridgeBio Pharma (BBIO): Exploring Valuation After a 20% Share Price Surge - Yahoo Finance

BridgeBio Pharma (BBIO): Exploring Valuation After a 20% Share Price Surge  Yahoo Finance

BridgeBio Pharma (BBIO): Exploring Valuation After a 20% Share Price Surge - Yahoo Finance

Click here to get full coverage on BridgeBio Pharma: Set For New Commercial Launches After Trial Successes - Seeking Alpha

BridgeBio Pharma: Set For New Commercial Launches After Trial Successes  Seeking Alpha

BridgeBio Pharma: Set For New Commercial Launches After Trial Successes - Seeking Alpha

Click here to get full coverage on Bernstein Initiates Coverage of BridgeBio Pharma (BBIO) with Outperform Recommendation - Nasdaq

Bernstein Initiates Coverage of BridgeBio Pharma (BBIO) with Outperform Recommendation  Nasdaq

Bernstein Initiates Coverage of BridgeBio Pharma (BBIO) with Outperform Recommendation - Nasdaq

Click here to get full coverage on BridgeBio Pharma Inc (BBIO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Rising ... - Yahoo Finance

BridgeBio Pharma Inc (BBIO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Rising ...  Yahoo Finance

BridgeBio Pharma Inc (BBIO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Rising ... - Yahoo Finance

Click here to get full coverage on BridgeBio Pharma (BBIO) Soars 17.1%: Is Further Upside Left in the Stock? - Yahoo Finance

BridgeBio Pharma (BBIO) Soars 17.1%: Is Further Upside Left in the Stock?  Yahoo Finance

BridgeBio Pharma (BBIO) Soars 17.1%: Is Further Upside Left in the Stock? - Yahoo Finance

Click here to get full coverage on BridgeBio Pharma, Inc. (BBIO) Retains $68 Target on Strong Launch Dynamics - Yahoo Finance

BridgeBio Pharma, Inc. (BBIO) Retains $68 Target on Strong Launch Dynamics  Yahoo Finance

BridgeBio Pharma, Inc. (BBIO) Retains $68 Target on Strong Launch Dynamics - Yahoo Finance

Click here to get full coverage on BridgeBio Pharma (BBIO) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance

BridgeBio Pharma (BBIO) Reports Q2 Loss, Beats Revenue Estimates  Yahoo Finance

BridgeBio Pharma (BBIO) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance

Click here to get full coverage on H.C. Wainwright Reiterates a Buy on BridgeBio Pharma (BBIO) - Yahoo Finance

H.C. Wainwright Reiterates a Buy on BridgeBio Pharma (BBIO)  Yahoo Finance

H.C. Wainwright Reiterates a Buy on BridgeBio Pharma (BBIO) - Yahoo Finance

Click here to get full coverage on BridgeBio Pharma Inc (BBIO) Q2 2025 Earnings Call Highlights: Record Revenue Surge and ... - Yahoo Finance

BridgeBio Pharma Inc (BBIO) Q2 2025 Earnings Call Highlights: Record Revenue Surge and ...  Yahoo Finance

BridgeBio Pharma Inc (BBIO) Q2 2025 Earnings Call Highlights: Record Revenue Surge and ... - Yahoo Finance

Click here to get full coverage on BridgeBio Pharma, Inc. (NASDAQ:BBIO) Is Expected To Breakeven In The Near Future - Yahoo Finance

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Is Expected To Breakeven In The Near Future  Yahoo Finance

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Is Expected To Breakeven In The Near Future - Yahoo Finance

Click here to get full coverage on BridgeBio (BBIO) Q3 2025 Earnings Call Transcript - AOL.com

BridgeBio (BBIO) Q3 2025 Earnings Call Transcript  AOL.com

BridgeBio (BBIO) Q3 2025 Earnings Call Transcript - AOL.com

Click here to get full coverage on Castleark Management LLC Cuts Position in BridgeBio Pharma, Inc. $BBIO - MarketBeat

Castleark Management LLC Cuts Position in BridgeBio Pharma, Inc. $BBIO  MarketBeat

Castleark Management LLC Cuts Position in BridgeBio Pharma, Inc. $BBIO - MarketBeat

Click here to get full coverage on BridgeBio Pharma (BBIO) Is Up 13.0% After Positive Phase 3 BBP-418 Results in Muscular Dystrophy - Yahoo Finance

BridgeBio Pharma (BBIO) Is Up 13.0% After Positive Phase 3 BBP-418 Results in Muscular Dystrophy  Yahoo Finance

BridgeBio Pharma (BBIO) Is Up 13.0% After Positive Phase 3 BBP-418 Results in Muscular Dystrophy - Yahoo Finance

Click here to get full coverage on BridgeBio Pharma (Nasdaq: BBIO) approves 34,199 inducement RSUs for 12 new employees - Stock Titan

BridgeBio Pharma (Nasdaq: BBIO) approves 34,199 inducement RSUs for 12 new employees  Stock Titan

BridgeBio Pharma (Nasdaq: BBIO) approves 34,199 inducement RSUs for 12 new employees - Stock Titan

Click here to get full coverage on Leerink Partners Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Raises Target Price to $86 - 富途牛牛

Leerink Partners Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Raises Target Price to $86  富途牛牛

Leerink Partners Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Raises Target Price to $86 - 富途牛牛

Click here to get full coverage on Interesting BBIO Put And Call Options For April 2026 - Nasdaq

Interesting BBIO Put And Call Options For April 2026  Nasdaq

Interesting BBIO Put And Call Options For April 2026 - Nasdaq

Click here to get full coverage on BBIO Stock Soars After Experimental Drug Shows Improvement In Inherited Muscle Disorder In Late-stage Trial - Stocktwits

BBIO Stock Soars After Experimental Drug Shows Improvement In Inherited Muscle Disorder In Late-stage Trial  Stocktwits

BBIO Stock Soars After Experimental Drug Shows Improvement In Inherited Muscle Disorder In Late-stage Trial - Stocktwits

Click here to get full coverage on Apuli Maricel, chief accounting officer, sells $148k in BridgeBio (BBIO) - Investing.com

Apuli Maricel, chief accounting officer, sells $148k in BridgeBio (BBIO)  Investing.com

Apuli Maricel, chief accounting officer, sells $148k in BridgeBio (BBIO) - Investing.com

Click here to get full coverage on BridgeBio Pharma director sells $13.2m in BBIO stock - Investing.com

BridgeBio Pharma director sells $13.2m in BBIO stock  Investing.com

BridgeBio Pharma director sells $13.2m in BBIO stock - Investing.com

Click here to get full coverage on BridgeBio Pharma CEO Kumar sells $5.9 million in BBIO stock - Investing.com

BridgeBio Pharma CEO Kumar sells $5.9 million in BBIO stock  Investing.com

BridgeBio Pharma CEO Kumar sells $5.9 million in BBIO stock - Investing.com

Click here to get full coverage on Insider Sale: Director at $BBIO Sells 61,031 Shares | BBIO Stock News - Quiver Quantitative

Insider Sale: Director at $BBIO Sells 61,031 Shares | BBIO Stock News  Quiver Quantitative

Insider Sale: Director at $BBIO Sells 61,031 Shares | BBIO Stock News - Quiver Quantitative

Click here to get full coverage on Kumar, BridgeBio Pharma CEO, sells $4.1m in BBIO stock - Investing.com

Kumar, BridgeBio Pharma CEO, sells $4.1m in BBIO stock  Investing.com

Kumar, BridgeBio Pharma CEO, sells $4.1m in BBIO stock - Investing.com

Click here to get full coverage on BridgeBio (NASDAQ: BBIO) to present FORTIFY interim topline Oct. 27; earnings Oct. 29 - Stock Titan

BridgeBio (NASDAQ: BBIO) to present FORTIFY interim topline Oct. 27; earnings Oct. 29  Stock Titan

BridgeBio (NASDAQ: BBIO) to present FORTIFY interim topline Oct. 27; earnings Oct. 29 - Stock Titan

Click here to get full coverage on BridgeBio Pharma (NASDAQ:BBIO) CEO Neil Kumar Sells 30,011 Shares - MarketBeat

BridgeBio Pharma (NASDAQ:BBIO) CEO Neil Kumar Sells 30,011 Shares  MarketBeat

BridgeBio Pharma (NASDAQ:BBIO) CEO Neil Kumar Sells 30,011 Shares - MarketBeat

Click here to get full coverage on BBIO Stock In Focus As Phase 3 Results And Q3 Earnings Approach - RTTNews

BBIO Stock In Focus As Phase 3 Results And Q3 Earnings Approach  RTTNews

BBIO Stock In Focus As Phase 3 Results And Q3 Earnings Approach - RTTNews

Click here to get full coverage on Why BridgeBio Pharma, Inc. (BBIO) Declined on Tuesday - Yahoo Finance

Why BridgeBio Pharma, Inc. (BBIO) Declined on Tuesday  Yahoo Finance

Why BridgeBio Pharma, Inc. (BBIO) Declined on Tuesday - Yahoo Finance

Click here to get full coverage on BridgeBio Pharma: Betting Big On Rare Disease Catalysts (NASDAQ:BBIO) - Seeking Alpha

BridgeBio Pharma: Betting Big On Rare Disease Catalysts (NASDAQ:BBIO)  Seeking Alpha

BridgeBio Pharma: Betting Big On Rare Disease Catalysts (NASDAQ:BBIO) - Seeking Alpha

Click here to get full coverage on UBS Reaffirms Buy on BridgeBio (BBIO) With Optimism Around Attruby Launch - Yahoo Finance

UBS Reaffirms Buy on BridgeBio (BBIO) With Optimism Around Attruby Launch  Yahoo Finance

UBS Reaffirms Buy on BridgeBio (BBIO) With Optimism Around Attruby Launch - Yahoo Finance

Click here to get full coverage on BridgeBio Pharma (BBIO) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance

BridgeBio Pharma (BBIO) Reports Q3 Loss, Beats Revenue Estimates  Yahoo Finance

BridgeBio Pharma (BBIO) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance

Click here to get full coverage on BridgeBio Pharma (BBIO): Assessing Valuation After Strong Encaleret Data and Pipeline Advances - Yahoo Finance

BridgeBio Pharma (BBIO): Assessing Valuation After Strong Encaleret Data and Pipeline Advances  Yahoo Finance

BridgeBio Pharma (BBIO): Assessing Valuation After Strong Encaleret Data and Pipeline Advances - Yahoo Finance

Click here to get full coverage on BridgeBio Pharma Inc (BBIO) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

BridgeBio Pharma Inc (BBIO) Q2 2025: Everything You Need To Know Ahead Of Earnings  Yahoo Finance

BridgeBio Pharma Inc (BBIO) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

Click here to get full coverage on GNTA, BBIO, AMRN Jump After Hours: Key Biotech Catalysts Driving Stock Gains - Nasdaq

GNTA, BBIO, AMRN Jump After Hours: Key Biotech Catalysts Driving Stock Gains  Nasdaq

GNTA, BBIO, AMRN Jump After Hours: Key Biotech Catalysts Driving Stock Gains - Nasdaq

Click here to get full coverage on BridgeBio Pharma (BBIO) Soars to All-Time High on Stellar Drug Trial Result - Yahoo Finance

BridgeBio Pharma (BBIO) Soars to All-Time High on Stellar Drug Trial Result  Yahoo Finance

BridgeBio Pharma (BBIO) Soars to All-Time High on Stellar Drug Trial Result - Yahoo Finance

Click here to get full coverage on Why BridgeBio Pharma, Inc. (BBIO) Surged on Wednesday - Yahoo Finance

Why BridgeBio Pharma, Inc. (BBIO) Surged on Wednesday  Yahoo Finance

Why BridgeBio Pharma, Inc. (BBIO) Surged on Wednesday - Yahoo Finance

Click here to get full coverage on 89,312 Shares in BridgeBio Pharma, Inc. $BBIO Acquired by WINTON GROUP Ltd - MarketBeat

89,312 Shares in BridgeBio Pharma, Inc. $BBIO Acquired by WINTON GROUP Ltd  MarketBeat

89,312 Shares in BridgeBio Pharma, Inc. $BBIO Acquired by WINTON GROUP Ltd - MarketBeat

Click here to get full coverage on BridgeBio Pharma (NASDAQ:BBIO) Stock Price Expected to Rise, Leerink Partners Analyst Says - MarketBeat

BridgeBio Pharma (NASDAQ:BBIO) Stock Price Expected to Rise, Leerink Partners Analyst Says  MarketBeat

BridgeBio Pharma (NASDAQ:BBIO) Stock Price Expected to Rise, Leerink Partners Analyst Says - MarketBeat

Click here to get full coverage on Invesco Ltd. Has $120.95 Million Stock Position in BridgeBio Pharma, Inc. $BBIO - MarketBeat

Invesco Ltd. Has $120.95 Million Stock Position in BridgeBio Pharma, Inc. $BBIO  MarketBeat

Invesco Ltd. Has $120.95 Million Stock Position in BridgeBio Pharma, Inc. $BBIO - MarketBeat

Click here to get full coverage on BridgeBio Pharma: Bullish On Attruby's Momentum And 2026 Catalysts (BBIO) - Seeking Alpha

BridgeBio Pharma: Bullish On Attruby's Momentum And 2026 Catalysts (BBIO)  Seeking Alpha

BridgeBio Pharma: Bullish On Attruby's Momentum And 2026 Catalysts (BBIO) - Seeking Alpha

Click here to get full coverage on BridgeBio Pharma (BBIO) Receives Maintained Rating with Raised P - GuruFocus

BridgeBio Pharma (BBIO) Receives Maintained Rating with Raised P  GuruFocus

BridgeBio Pharma (BBIO) Receives Maintained Rating with Raised P - GuruFocus

Click here to get full coverage on BridgeBio Pharma Stock (BBIO) Opinions on Analyst Buy Ratings and Attruby Launch - Nasdaq

BridgeBio Pharma Stock (BBIO) Opinions on Analyst Buy Ratings and Attruby Launch  Nasdaq

BridgeBio Pharma Stock (BBIO) Opinions on Analyst Buy Ratings and Attruby Launch - Nasdaq

Click here to get full coverage on Federated Hermes Inc. Takes Position in BridgeBio Pharma, Inc. $BBIO - MarketBeat

Federated Hermes Inc. Takes Position in BridgeBio Pharma, Inc. $BBIO  MarketBeat

Federated Hermes Inc. Takes Position in BridgeBio Pharma, Inc. $BBIO - MarketBeat

Click here to get full coverage on HC Wainwright & Co. Maintains BridgeBio Pharma (BBIO) Buy Recommendation - Nasdaq

HC Wainwright & Co. Maintains BridgeBio Pharma (BBIO) Buy Recommendation  Nasdaq

HC Wainwright & Co. Maintains BridgeBio Pharma (BBIO) Buy Recommendation - Nasdaq

Click here to get full coverage on BridgeBio (NASDAQ: BBIO) sets 8:00 a.m. ET call on Encaleret CALIBRATE Phase 3 readout - Stock Titan

BridgeBio (NASDAQ: BBIO) sets 8:00 a.m. ET call on Encaleret CALIBRATE Phase 3 readout  Stock Titan

BridgeBio (NASDAQ: BBIO) sets 8:00 a.m. ET call on Encaleret CALIBRATE Phase 3 readout - Stock Titan

Click here to get full coverage on BridgeBio Pharma (BBIO): Assessing Valuation After Strong Attruby Quarter and Upbeat Analyst Outlook - simplywall.st

BridgeBio Pharma (BBIO): Assessing Valuation After Strong Attruby Quarter and Upbeat Analyst Outlook  simplywall.st

BridgeBio Pharma (BBIO): Assessing Valuation After Strong Attruby Quarter and Upbeat Analyst Outlook - simplywall.st

Click here to get full coverage on HC Wainwright & Co. Reiterates BridgeBio Pharma (BBIO) Buy Recommendation - Nasdaq

HC Wainwright & Co. Reiterates BridgeBio Pharma (BBIO) Buy Recommendation  Nasdaq

HC Wainwright & Co. Reiterates BridgeBio Pharma (BBIO) Buy Recommendation - Nasdaq

Click here to get full coverage on HighVista Strategies LLC Increases Stock Position in BridgeBio Pharma, Inc. $BBIO - MarketBeat

HighVista Strategies LLC Increases Stock Position in BridgeBio Pharma, Inc. $BBIO  MarketBeat

HighVista Strategies LLC Increases Stock Position in BridgeBio Pharma, Inc. $BBIO - MarketBeat

Click here to get full coverage on $BBIO stock is up 16% today. Here's what we see in our data. - Quiver Quantitative

$BBIO stock is up 16% today. Here's what we see in our data.  Quiver Quantitative

$BBIO stock is up 16% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on New Analyst Forecast: $BBIO Given $90.0 Price Target | BBIO Stock News - Quiver Quantitative

New Analyst Forecast: $BBIO Given $90.0 Price Target | BBIO Stock News  Quiver Quantitative

New Analyst Forecast: $BBIO Given $90.0 Price Target | BBIO Stock News - Quiver Quantitative

Click here to get full coverage on BridgeBio Pharma CEO Kumar sells $5.9 million in BBIO stock By Investing.com - Investing.com South Africa

BridgeBio Pharma CEO Kumar sells $5.9 million in BBIO stock By Investing.com  Investing.com South Africa

BridgeBio Pharma CEO Kumar sells $5.9 million in BBIO stock By Investing.com - Investing.com South Africa

Click here to get full coverage on BridgeBio Pharma (NASDAQ:BBIO) Hits New 12-Month High - Time to Buy? - MarketBeat

BridgeBio Pharma (NASDAQ:BBIO) Hits New 12-Month High - Time to Buy?  MarketBeat

BridgeBio Pharma (NASDAQ:BBIO) Hits New 12-Month High - Time to Buy? - MarketBeat

Click here to get full coverage on Wolfe Research Initiates Coverage of BridgeBio Pharma (BBIO) with ‘Outperform’ Rating - Yahoo Finance

Wolfe Research Initiates Coverage of BridgeBio Pharma (BBIO) with ‘Outperform’ Rating  Yahoo Finance

Wolfe Research Initiates Coverage of BridgeBio Pharma (BBIO) with ‘Outperform’ Rating - Yahoo Finance

Click here to get full coverage on Panagora Asset Management Inc. Boosts Stake in BridgeBio Pharma, Inc. $BBIO - MarketBeat

Panagora Asset Management Inc. Boosts Stake in BridgeBio Pharma, Inc. $BBIO  MarketBeat

Panagora Asset Management Inc. Boosts Stake in BridgeBio Pharma, Inc. $BBIO - MarketBeat

Click here to get full coverage on BridgeBio Pharma (BBIO) Opinions on $300 Million Royalty Financing Deal - Nasdaq

BridgeBio Pharma (BBIO) Opinions on $300 Million Royalty Financing Deal  Nasdaq

BridgeBio Pharma (BBIO) Opinions on $300 Million Royalty Financing Deal - Nasdaq

Click here to get full coverage on BridgeBio Pharma Inc. (BBIO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

BridgeBio Pharma Inc. (BBIO) Stock Price | Live Quotes & Charts | NASDAQ  StocksToTrade

BridgeBio Pharma Inc. (BBIO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Click here to get full coverage on First Week of BBIO May 2026 Options Trading - Nasdaq

First Week of BBIO May 2026 Options Trading  Nasdaq

First Week of BBIO May 2026 Options Trading - Nasdaq

Click here to get full coverage on How Investors May Respond To BridgeBio Pharma (BBIO) Strong Attruby Sales, Wider Losses, And CEO Stock Sale - simplywall.st

How Investors May Respond To BridgeBio Pharma (BBIO) Strong Attruby Sales, Wider Losses, And CEO Stock Sale  simplywall.st

How Investors May Respond To BridgeBio Pharma (BBIO) Strong Attruby Sales, Wider Losses, And CEO Stock Sale - simplywall.st

Click here to get full coverage on Tema Etfs LLC Sells 25,530 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat

Tema Etfs LLC Sells 25,530 Shares of BridgeBio Pharma, Inc. $BBIO  MarketBeat

Tema Etfs LLC Sells 25,530 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat

Click here to get full coverage on $BBIO stock is up 2% today. Here's what we see in our data. - Quiver Quantitative

$BBIO stock is up 2% today. Here's what we see in our data.  Quiver Quantitative

BBIO

Price Chart

Key Statistics

Technicals

About BBIO

Latest News

BridgeBio Has More Room To Run (NASDAQ:BBIO) - Seeking Alpha

This Biotech Is On A Triple-Digit Run, And Shows No Signs Of Slowing - Investor's Business Daily

BridgeBio Pharma (NASDAQ:BBIO) Reaches New 12-Month High - Here's Why - MarketBeat

Advanced Charts

Top Gainers

Top Losers